Evidence map›Paper›PMID 14613582›Full record

ArticleMolecular cancer2003

p8 inhibits the growth of human pancreatic cancer cells and its expression is induced through pathways involved in growth inhibition and repressed by factors promoting cell growth.

Cédric Malicet, Nathalie Lesavre, Sophie Vasseur, Juan L Iovanna

Open access · goldAbstract read
In one paragraph

Article in Molecular cancer, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 54 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. PPAR research · 2023
    Article
  5. Loss ofHaematologica · 2022
    Article
  6. Oncogenic Role of NUPR1 in Ovarian Cancer.OncoTargets and therapy · 2020
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Regulation of apoptosis by the p8/prothymosin alpha complex.Proceedings of the National Academy of Sciences of the United States of America · 2006
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Cédric MalicetCentre de Recherche INSERM, EMI 0116, 163 Avenue de Luminy, Case 915, Parc Scientifique et Technologique de Luminy, 13288 Marseille Cedex, France. malicet@marseille.inserm.fr
Nathalie Lesavre
Sophie Vasseur
Juan L Iovanna
Inserm · FRCentre de Physique Théorique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundp8 is a stress-induced protein with multiple functions and biochemically related to the architectural factor HMG-I/Y. We analyzed the expression and function of p8 in pancreatic cancer-derived cells.

methodsExpression of p8 was silenced in the human pancreatic cancer cell lines Panc-1 and BxPc-3 by infection with a retrovirus expressing p8 RNA in the antisense orientation. Cell growth was measured in control and p8-silenced cells. Influence on p8 expression of the induction of intracellular pathways promoting cellular growth or growth arrest was monitored.

resultsp8-silenced cells grew more rapidly than control cells transfected with the empty retrovirus. Activation of the Ras-->Raf-->MEK-->ERK and JNK intracellular pathways down-regulated p8 expression. In addition, the MEK1/2 inhibitor U0126 and the JNK inhibitor SP600125 up-regulates expression of p8. Conversely, p38 or TGFbeta-1 induced p8 expression whereas the specific p38 inhibitor SB203580 down-regulated p8 expression. Finally, TGFbeta-1 induction was in part mediated through p38.

conclusionsp8 inhibits the growth of human pancreatic cancer cells. p8 expression is induced through pathways involved in growth inhibition and repressed by factors that promote cell growth. These results suggest that p8 belongs to a pathway regulating the growth of pancreatic cancer cells.

Indexed as

AnthracenesBasic Helix-Loop-Helix ProteinsButadienesCell Line, TumorCell ProliferationCulture MediaCulture Media, Serum-FreeDNA-Binding ProteinsEnzyme InhibitorsGene Expression Regulation, NeoplasticGene SilencingGenetic VectorsGrowth InhibitorsHumansImidazolesJNK Mitogen-Activated Protein KinasesAnthracenesBasic Helix-Loop-Helix ProteinsButadienesCulture MediaCulture Media, Serum-FreeDNA-Binding ProteinsEnzyme InhibitorsGrowth InhibitorsImidazolesJNK Mitogen-Activated Protein KinasesMitogen-Activated Protein KinasesNeoplasm ProteinsNitrilesNUPR1 protein, humanProto-Oncogene Proteins c-rafpyrazolanthronePyridinesras ProteinsRNA, AntisenseSB 203580TGFB1 protein, humanTransforming Growth Factor betaTransforming Growth Factor beta1U 0126

Identifiers

PMID14613582
PMCPMC280693
OpenAlexW2102362155

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.